Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2013; 19(44): 7955-7971
Published online Nov 28, 2013. doi: 10.3748/wjg.v19.i44.7955
Published online Nov 28, 2013. doi: 10.3748/wjg.v19.i44.7955
Figure 1 Main angiogenesis pathways involving vascular endothelial growth factor and the interactions with anti-angiogenic target drugs.
VEGF: Vascular endothelial growth factor. HIF: Hypoxia-inducible factor; EGF: Epidermal growth factor; EGFR: Epidermal growth factor receptor; VEGFR: Vascular endothelial growth factor receptor; PIGF: Placental growth factor.
- Citation: Marques I, Araújo A, Mello RA. Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives. World J Gastroenterol 2013; 19(44): 7955-7971
- URL: https://www.wjgnet.com/1007-9327/full/v19/i44/7955.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i44.7955